Company intelligence / Profile preview
OliPass Corporation
South Koreaolipass.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
OliPass Corporation develops next-generation RNA therapeutics using its proprietary PNA platform technology. The company's approach centers on inducing exon skipping via cell-permeable PNAs, enabling discovery of multiple new drug candidates. While it has an expanding pipeline targeting various disease genes, most programs appear to be at preclinical or early clinical stages. The company aims for global impact through partnerships and collaborations with pharmaceutical companies.
- Therapeutic areas
- Other
- Modalities
- Peptide Nucleic Acid (PNA)-based therapeuticsRNA therapeuticsExon skipping agents
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →03
Partnerships
Plans active collaboration with pharmaceutical and biotech companies for co-development of OPNA-based drugs, but no named partners listed yet.
Beyond the preview
Go deeper on OliPass Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OliPass Corporation.